Authored By: Sarah
23 Oct 2024

increasing prevalence of chronic disorders is driving the Blood-Grouping Reagents Market

Latest News:- Blood-Grouping Reagents Market: Hospitals and blood banks is expected to lead the End-user segment during 2024-2028

Technavio analyzes that the Blood-Grouping Reagents Market is expected to grow at a CAGR of 8.13% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 520.68 million.There are various factors that contribute to the growth of the market. The blood-grouping reagents market is experiencing significant growth due to the increasing prevalence of chronic disorders and the subsequent need for frequent blood transfusions. These reagents play a crucial role in identifying the blood type of donors and recipients, ensuring compatibility and preventing transfusion reactions. The rising demand for safe and effective blood-grouping reagents is driving market growth, with key players investing in research and development to innovate and improve their offerings.

The hospitals and healthcare facilities segment dominates the global blood-grouping reagents market due to the significant usage of these reagents in inventory management for blood transfusion services. The increasing prevalence of blood cancers and other chronic conditions, leading to higher hospitalizations, fuels the demand for blood-grouping reagents. In emergency situations, such as road accidents or cardiac arrests, quick identification of blood groups through assay-based techniques, like serology, is crucial for timely and effective treatment. Consequently, blood-grouping reagents are extensively utilized in emergency departments, urgent care centers, and intensive care units (ICUs) of hospitals, where efficiency and accuracy are paramount. Arena BioScience and other key players cater to this segment with advanced solutions, including artificial intelligence and automation, to streamline inventory management and improve diagnostic accuracy. 

Know which region is leading the market growth by requesting a sample report

Blood-Grouping Reagents Market Segmentation

  • End-user
    • Hospitals and blood banks
    • Clinical laboratories
    • Academic and research institutes
  • Technique
    • PCR-based and microarray techniques
    • Assay-based techniques
    • Massively parallel sequencing techniques
    • Serology
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • AliveDX
  • Arena Bio Scien
  • ARKRAY Inc.
  • Atlas Medical GmbH
  • BAG Health Care GmbH
  • Bio Rad Laboratories Inc.
  • Calibre Scientific Inc.
  • Danaher Corp.
  • DIAGAST SAS
  • Grifols SA
  • Merck KGaA
  • Novacyt SA
  • QuidelOrtho Corp.
  • Rapid Labs Ltd.
  • Thermo Fisher Scientific Inc.
  • Torax Biosciences Ltd.
  • Tulip Diagnostics Pvt. Ltd.
  • Fortress Diagnostics
  • Paragon Care Ltd.
  • VitroScient

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Blood-Grouping Reagents Market involves the production and supply of antigens and antibodies used for identifying and typing different blood groups, including ABO and Rh factor. Companies like Novacyt Group and Ortho Clinical Diagnostics dominate this market. These reagents play a crucial role in blood transfusions, chronic diseases treatment, and accident victims' care, ensuring blood safety and proper inventory management. Blood typing processes, such as cross-matching, PCR-based and microarray, assay-based, massively parallel sequencing, antibody screening, and HLA typing, are essential for hospitals, blood banks, and transplantation procedures using red blood cells.

Market Research Overview

The global blood-grouping reagents market is a significant segment of the expansive life sciences tools and services industry. According to Technavio, this market is integrated within the larger life sciences tools and services market, which encompasses firms involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables. These tools and services are utilized for R&D on pharmaceuticals and biotechnology products, as well as laboratory diagnosis of various diseases. Furthermore, the market includes life sciences-related services such as contract research, contract manufacturing, and contract sales. The global healthcare market size is determined by Technavio based on the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Key components of this market include antigens, antibodies, blood group typing, Rh factor, and blood banks.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio